TEVA - Moodle Lille 2

Du générique à la
société
pharmaceutique
classique
Casaert Hélène Duvinage Elodie Fovez Emilie

TEVA Hélène Casaert - Elodie Duvinage - Emilie Fovez
Teva Pharmaceutical Industries Ltd. is an israelian company
specializing in :
–Generics
–Branded and proprietary pharmaceuticals
–Active Pharmaceutical Ingredients (API)
A leading global supplier of API
Among the top 20 pharmaceutical companies
One of the largest generic pharmaceutical companies in the world

TEVA Hélène Casaert - Elodie Duvinage - Emilie Fovez
•Among the most traded shares
Tel Aviv stock exchange
NASDAQ
Seaq International in London
Frankfurt stock exchange
•60 countries - 26 000 employees
•80% of Teva ‘s sales are in North America and Europe
•17th global rank of pharmaceuticals laboratories
10th in France
•1st global rank of generics pharmaceuticals laboratories
4th in France
•$8.4 billion in 2006

TEVA Hélène Casaert - Elodie Duvinage - Emilie Fovez
Israel
Corporate HQ
Marketing
R&D
Production
France
Marketing
R&D
Production
USA
Marketing
R&D
Production
Canada
Marketing
R&D
Production
Argentina
Marketing
R&D
Production
South Africa
Marketing
Kenya
Marketing
Singapore
Marketing
Netherlands
Marketing
R&D
Production
Hungary
Marketing
R&D
Production
India
Marketing
R&D
Production
Mexico
Marketing
R&D
Production
Switzerland
Marketing
Sweden &
Scandinavia
Marketing
Russia
Ukraine
Latvia + CIS
Marketing
Brazil
Marketing
Bulgaria
Marketing
China
Marketing
Production
Lithuania
Marketing
R&D
Production
Czech Rep
Marketing
R&D
Production
Germany
Marketing
R&D
Production
Poland
Marketing
Production
Chile
Marketing
R&D
Production
Peru
Marketing
R&D
Production
Venezuela
Marketing
R&D
Production
Uruguay
Marketing
Japan
Marketing
Italy
Marketing
R&D
Production
UK & Ireland
Marketing
R&D
Production
Portugal
Marketing
Spain
Marketing
Belgium
Marketing
R&D
Romania
Marketing
Taiwan
Marketing
Slovakia
Marketing
Curacao
Marketing
TEVA dans le monde

TEVA Hélène Casaert - Elodie Duvinage - Emilie Fovez
Événements clés dans l’histoire de
Teva
1901 Fondation de TEVA à Jérusalem
1933 Devient un laboratoire pharmaceutique fabricant de
matières premières et de produits finis
1951 1ère cotation sur la bourse de Tel-Aviv
1976 Fusion des 3 compagnies Assia, Zori et Teva
Formation du groupe Teva Pharmaceutical Industries
Début de l’exportation et ouverture de nouveaux marchés
1980 Acquisition d’Ikapharm, son concurrent n°2 en Israël
consolide sa position interne
accès au marché US grâce à la séparation de la
production pénicilline / non pénicilline requise par les autorités
internationales